Sustained GM-CSF and PEI condensed pDNA presentation increases the level and duration of gene expression in dendritic cells

被引:23
作者
Ali, Omar A. [1 ]
Mooney, David J. [1 ]
机构
[1] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA
关键词
Dendritic cell; Vaccine; T-cell; Gene expression; pDNA; Protein assay; GM-CSF; Immunotherapy;
D O I
10.1016/j.jconrel.2008.07.005
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Current techniques to educate dendritic cells (DCs) ex vivo for immunotherapy are plagued by inefficient protocols and DC modifications are often transient and lost upon transplantation. This study investigated the role of sustained presentation of GM-CSF and PEI condensed pDNA (PEI-DNA) on gene transfer and long-term gene expression. Appropriate GM-CSF signaling during DC transfection promoted PEI-DNA uptake, although high cytokine concentrations induced intercellular DNA degradation, indicating the need for controlled presentation. Poly(lactide-co-glycolide) scaffolds that continuously stimulated DCs with both GM-CSF and PEI-DNA led to a 20-fold increase in gene expression, and high levels of expression persisted for a period of 10 days, in vitro. These results encourage the exploitation of biomaterials and GM-CSF to develop novel delivery vectors for genetically modified DCs or to genetically program host DCs in situ for vaccination and the treatment of autoimmunity. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:273 / 278
页数:6
相关论文
共 43 条
[1]  
ALI OA, 2006, CELL TRANSPLANT, P591
[2]   Alginate hydrogels as biomaterials [J].
Augst, Alexander D. ;
Kong, Hyun Joon ;
Mooney, David J. .
MACROMOLECULAR BIOSCIENCE, 2006, 6 (08) :623-633
[3]   Gene therapy meets vaccine development [J].
Collins, MK ;
Cerundolo, V .
TRENDS IN BIOTECHNOLOGY, 2004, 22 (12) :623-626
[4]  
Cristiano RJ, 1998, ANTICANCER RES, V18, P3241
[5]   PLGA:: Poloxamer and PLGA:: Poloxamine blend nanostructures as carriers for nasal gene delivery [J].
Csaba, N. ;
Sanchez, A. ;
Alonso, M. J. .
JOURNAL OF CONTROLLED RELEASE, 2006, 113 (02) :164-172
[6]   High efficiency adenovirus-mediated gene transfer to human dendritic cells [J].
Dietz, AB ;
Vuk-Pavlovic, S .
BLOOD, 1998, 91 (02) :392-398
[7]  
Disis Mary L, 2005, Oncology (Williston Park), V19, P5
[8]   DNA vaccines: Progress and challenges [J].
Donnelly, JJ ;
Wahren, B ;
Liu, MA .
JOURNAL OF IMMUNOLOGY, 2005, 175 (02) :633-639
[9]   GM-CSF-based cancer vaccines [J].
Dranoff, G .
IMMUNOLOGICAL REVIEWS, 2002, 188 :147-154
[10]   Cytokines in cancer pathogenesis and cancer therapy [J].
Dranoff, G .
NATURE REVIEWS CANCER, 2004, 4 (01) :11-22